Russell Investments Group’s Oric Pharmaceuticals ORIC Stock Holding History

Russell Investments Group’s Portfolio ORIC Stock Details ORIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.08M	Sell	99,742 -163,317	-62%	-$1.48M	﹤0.01%	2428
2026 Q1	$3.33M	Buy	263,059 +56,022	+27%	+$636K	﹤0.01%	1583
2025 Q4	$1.69M	Buy	207,037 +202,063	+4,062%	+$2.33M	﹤0.01%	1965
2025 Q3	$59.7K	Buy	+4,974	New	+$52.3K	﹤0.01%	3207
2024 Q3	–	Sell	-1,105	Closed	-$7.81K	–	3765
2024 Q2	$7.81K	Buy	+1,105	New	+$9.89K	﹤0.01%	3130
2023 Q4	–	Sell	-28	Closed	-$169	–	3281
2023 Q3	$169	Buy	+28	New	+$229	﹤0.01%	3502
2022 Q2	–	Sell	-1,004	Closed	-$5K	–	2947
2022 Q1	$5K	Hold	1,004	–	–	﹤0.01%	2728
2021 Q4	$14K	Hold	1,004	–	–	﹤0.01%	2965
2021 Q3	$20K	Buy	+1,004	New	+$20.4K	﹤0.01%	2997

Other funds holding ORIC

Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

SOCM

SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Russell Investments Group's ORIC Position: Q2 2026 in Review

Russell Investments Group reduced its Oric Pharmaceuticals (ORIC) stake by 62% in Q2 2026, selling an estimated $1.48M and leaving 99,742 shares worth $1.08M. The position accounts for ﹤0.01% of the portfolio, ranked #2428.

Russell Investments Group first reported a position in ORIC in Q3 2021 and has held it in 9 quarters since. The position peaked at $3.33M in Q1 2026. 180 funds tracked by Wall St. Rank hold ORIC as of Q2 2026.

Russell Investments Group held 99,742 shares of Oric Pharmaceuticals worth $1.08M as of Q2 2026.
Russell Investments Group sold 163,317 Oric Pharmaceuticals shares in Q2 2026, an estimated $1.48M.
Oric Pharmaceuticals made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #2428 holding.
Russell Investments Group first reported a position in Oric Pharmaceuticals in Q3 2021 and has held it in 9 quarters since.
Russell Investments Group's Oric Pharmaceuticals position peaked at $3.33M in Q1 2026.
180 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.